To the Editor We commend Ye et al for their comprehensive analysis of fracture risk using the Fracture Risk Assessment Tool (FRAX) in individuals with cancer. This study provides valuable insights into fracture risk among patients with cancer, an area that warrants attention due to the unique health challenges faced by this population. However, several methodological and interpretive aspects merit further consideration to enhance the robustness and generalizability of the findings.